Pancreatic cancer in a patient with myasthenia gravis.

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67

Myasthenia gravis. N Engl J Med (1994) 5.11

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23

Late mortality after surgery for peptic ulcer. N Engl J Med (1982) 2.73

Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37

Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst (1986) 1.95

Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology (1996) 1.23

Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med (1987) 1.19

Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg (1988) 1.18

Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol (1999) 1.10

Paraneoplastic syndromes. Arch Neurol (1999) 1.04

Pancreatic cancer risk following gastric surgery. Cancer (1987) 0.93

Concomitant neoplasia in pancreatic cancer. Cancer (1982) 0.83

Endocrinopathy associated with pancreatic carcinomas. Review of host factors including hyperplasia and gonadotropic activity. Ann Surg (1966) 0.81

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2000. A 69-year-old man with myasthenia gravis and a mediastinal mass. N Engl J Med (2000) 0.79

Zollinger-Ellison syndrome associated with ductal adenocarcinoma of the pancreas. N Engl J Med (1978) 0.79

Current concepts in pancreatic cancer: symposium summary. Pancreas (1998) 0.78

Myasthenia gravis with a paraneoplastic marker. J Neuroophthalmol (2000) 0.78

[Late onset myasthenia: 34 cases in patients over 65 years of age]. Rev Neurol (Paris) (1997) 0.78

Stroke and cardiac arrhythmias. J Stroke Cerebrovasc Dis (2007) 1.01

Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol (2009) 0.88

Disappearance of haemorrhagic stroke-induced thalamic (central) pain following a further (contralateral ischaemic) stroke. Funct Neurol (2003) 0.75